Mill Creek Capital Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Mill Creek Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $580 - $2,403	-2,072 Reduced 2.4%	84,120 $27,000
Q1 2024 May 14, 2024	BUY	$1.06 - $1.67 $2,196 - $3,460	2,072 Added 2.46%	86,192 $99,000
Q3 2023 Nov 14, 2023	SELL	$1.61 - $2.54 $1,637 - $2,583	-1,017 Reduced 1.19%	84,120 $152,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $1,159 - $1,983	1,017 Added 1.21%	85,137 $158,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $11,955 - $21,818	-9,963 Reduced 10.59%	84,120 $111,000
Q4 2022 May 25, 2023	BUY	$1.63 - $3.52 $475 - $1,027	292 Added 0.35%	84,412 $143 Million
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $153,355 - $331,172	94,083 New	94,083 $0

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Mill Creek Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mill Creek Capital Advisors, LLC with notifications on news.